Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 1, 1997

View Archived Issues

Novartis reports new NPY antagonists with selectivity for Y5 receptors

University of Minnesota researchers report kappa-receptor ligands

Esteve describes glutamate release inhibitors

Leo discloses new vitamin D analogues

Pharmacia & Upjohn: Q2 1997 highlights

MGI Pharma: Q2 1997 highlights

Centocor: Q2 1997 highlights

Neoral as rheumatoid arthritis therapy launched in U.S.

New application for long-established local anesthetic

NeoTherapeutics reports interim results from clinical trial with AIT-082

NIH study shows TB prophylaxis unnecessary in HIV-infected patients

Vyrex awarded U.S. patent for CD-Tagging

Cel-Sci allowed patent for immune system technology

Grepafloxacin efficacy in respiratory infections reported

Aronex: Q2 1997 highlights

Xoma issued further U.S. patents based on BPI platform

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...